Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 12 subfamily D member 3 (OR12D3) is a protein-coding gene in humans that encodes a member of the olfactory receptor family, which are G protein-coupled receptors responsible for the detection of odorant molecules in the nose[1][3][4][5][6]. OR12D3 shares the characteristic seven-transmembrane domain structure of GPCRs and is part of the largest gene family in the human genome[1][3][5]. Although primarily involved in olfaction, genetic variants in OR12D3 have been associated in genome-wide association studies with a variety of phenotypes and diseases, including cancer, autoimmune and neuropsychiatric disorders, and other complex traits[1]. There are no known drugs directly targeting OR12D3, and its direct therapeutic potential is not currently established, but it remains a biologically relevant receptor as part of odorant signaling and as a locus associated with disease susceptibility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 12 subfamily D member 3 (OR12D3).